Envision Pharma Group has acquired medical writing company ProScribe.

Queensland, Australia-based ProScribe provides data dissemination services to academia, biopharmaceutical companies and medical device companies in the Asia-Pacific region.

Envision, headquartered in Southport, Conn., provides technology and scientific communications to pharmaceutical, biotechnology and medical device companies. The acquisition will allow the company to expand into the Asia-Pacific region.

The buyer is backed by Washington, D.C. private equity firm the Halifax Group. Halifax acquired Envision in June.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.